Patient Perspective of the Corporate Reputation of Pharma in Asia, 2017-2018
Dublin, Aug. 16, 2019 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma, 2017 - The Patient Perspective - Asia Edition" report has been added to ResearchAndMarkets.com's offering.
Introducing the results of the 2017 (2nd) edition of The Corporate Reputation of Pharma-from the Perspective of Asian Patient Groups'. In total, 101 Asian patient groups from across the region participated in the 2017 survey (with 35% of the respondents being based in Australasia).
The 18 companies included in the 2017 Asia analysis are: AbbVie, Astellas Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly (Lilly), Gilead Sciences, GSK, Janssen, Merck & Co/MSD, Novartis, Otsuka, Pfizer, Roche, Sanofi and Takeda.
Asian patient groups (and the patients they represent), on the whole, take a more positive view of the pharmaceutical industry than patient groups from elsewhere in the world. As many as 51% of the respondent Asian patient groups stated that the pharmaceutical industry as a whole had an Excellent or Good corporate reputation in 2017 (on a par with the 50% of Asian patient groups saying the same in 2016). The equivalent figure from patient groups worldwide in 2017 was 43%.
Key Topics Covered:
- Executive Summary
- The Relationships That Asian Patient Groups Have With Pharma, 2017
- Industry-Wide Findings From Asian Patient Groups, 2017
- Rankings Of The 18 Pharma Companies, 2017 V. 2016 Among Asian Patient Groups Familiar With The Companies
- Positionings Of 11 Pharma Companies, 2017 V. 2016 Among Asian Patient Groups That Work/Partner With The Companies
- Profiles Of The 18 Companies, 2017
Appendices
I. Asian Patient Groups: Their Views On Pharma And Their Recommendations For Improvement
II. Profiles Of The 101 Respondent Asian Patient Groups, 2017
Companies Mentioned
- AbbVie
- Astellas Pharma
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Eisai
- Eli Lilly (Lilly)
- GSK
- Gilead Sciences
- Janssen
- Merck & Co/MSD
- Novartis
- Otsuka
- Pfizer
- Roche
- Sanofi
- Takeda
For more information about this report visit https://www.researchandmarkets.com/r/smwnkv
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900